Recombinant Edwardsiella ictaluri Xaa-Pro dipeptidase (pepQ)

What is Edwardsiella ictaluri Xaa-Pro dipeptidase (pepQ) and what is its significance in research?

Xaa-Pro dipeptidase (pepQ) from Edwardsiella ictaluri is a 443-amino acid enzyme belonging to the EC class 3.4.13.9 . This enzyme catalyzes the cleavage of dipeptides containing proline at the C-terminal position. The significance of studying this enzyme lies in several areas:

• Understanding bacterial metabolism and protein turnover

• Investigating potential roles in bacterial pathogenesis

• Exploring structural and functional relationships among bacterial peptidases

• Developing potential targets for antimicrobial interventions

The pepQ gene has been identified in E. ictaluri strain 93-146 , and computational structure models indicate a high confidence structure (pLDDT global score of 96.88) , making it a reliable target for structural biology research.

What expression systems are most effective for recombinant E. ictaluri pepQ production?

For recombinant expression of E. ictaluri proteins, balanced-lethal systems have shown effectiveness. These systems use complementation of an essential gene deletion to maintain plasmids without antibiotic selection. Based on successful approaches with other E. ictaluri proteins:

• E. coli-based expression systems:

  • BL21(DE3) or similar strains carrying pET-based vectors with inducible T7 promoters

  • Expression can be optimized using various tags (His, GST, MBP) to enhance solubility and facilitate purification

• Homologous expression in attenuated E. ictaluri:

  • The balanced-lethal system based on asd complementation has been successfully used for expressing recombinant proteins in E. ictaluri

  • This approach involves construction of Asd+ plasmids and transformation into E. ictaluri ΔasdA01 strains

When using E. ictaluri as an expression host, it's critical to ensure appropriate supplementation with diaminopimelic acid (DAP) during the growth and selection phases, as described in protocols for E. ictaluri ΔasdA01 construction .

What purification strategies yield high-purity recombinant E. ictaluri pepQ?

For efficient purification of recombinant E. ictaluri pepQ, a multi-step strategy is recommended:

Step 1: Initial capture

• Immobilized metal affinity chromatography (IMAC) for His-tagged pepQ

• Glutathione affinity chromatography for GST-tagged pepQ

Step 2: Intermediate purification

• Ion exchange chromatography based on the theoretical pI of pepQ

• Size exclusion chromatography to separate pepQ from aggregates or degradation products

Step 3: Polishing

• Hydrophobic interaction chromatography

• A second round of size exclusion chromatography under native buffer conditions

Sample buffer optimization:
For maximal stability and activity, maintain pepQ in buffers containing:

• 50 mM Tris-HCl or phosphate buffer (pH 7.0-8.0)

• 100-150 mM NaCl

• 1-5 mM DTT or 2-ME (to maintain reduced states of cysteine residues)

• 5-10% glycerol (to enhance stability)

Successful E. ictaluri protein purification has been achieved using similar strategies, as evidenced by studies on other E. ictaluri proteins .

How can researchers verify the enzymatic activity of purified recombinant E. ictaluri pepQ?

To verify the enzymatic activity of purified recombinant E. ictaluri pepQ, a systematic approach involving multiple methodologies is recommended:

• Spectrophotometric assays:

  • Using chromogenic substrates such as X-Pro-p-nitroanilide compounds

  • Monitoring the release of p-nitroaniline at 405 nm

  • Standard reaction conditions: 50 mM Tris-HCl (pH 7.5), 1 mM substrate, 37°C

• HPLC-based peptide cleavage assays:

  • Using dipeptide substrates (e.g., Ala-Pro, Gly-Pro)

  • Monitoring substrate disappearance and product formation by reverse-phase HPLC

  • Quantifying cleavage products using appropriate standards

• Specific activity calculation:

  • One unit defined as the amount of enzyme that catalyzes the hydrolysis of 1 μmol of substrate per minute

  • Specific activity expressed as units/mg protein

  • Protein concentration determined using BCA or Bradford assays

• Controls to include:

  • Heat-inactivated enzyme (negative control)

  • Commercial Xaa-Pro dipeptidase if available (positive control)

  • Assays with and without potential inhibitors (e.g., metalloprotease inhibitors)

Activity measurements are critical for confirming that the recombinant protein retains its native function after the purification process.

What approaches can be used to solve the crystal structure of E. ictaluri pepQ?

While computational models of E. ictaluri pepQ exist with high confidence scores (pLDDT 96.88) , experimental structure determination provides crucial validation. A comprehensive crystallization strategy includes:

• Pre-crystallization considerations:

  • Ensure protein purity >95% by SDS-PAGE and size exclusion chromatography

  • Verify monodispersity through dynamic light scattering

  • Optimize buffer conditions using thermal shift assays

• Initial screening:

  • Commercial sparse matrix screens (Hampton Research, Molecular Dimensions)

  • Sitting drop vapor diffusion method at 18°C and 4°C

  • Protein concentrations ranging from 5-15 mg/ml

• Optimization strategies:

  • Fine grid screening around initial hits

  • Additive screening to improve crystal quality

  • Seeding techniques to control nucleation

  • Co-crystallization with substrates or inhibitors

• Data collection and processing:

  • Cryoprotection optimization

  • Synchrotron radiation source for high-resolution data

  • Data processing with XDS or MOSFLM

  • Molecular replacement using homologous structures as search models

• Structure refinement and validation:

  • Iterative model building and refinement

  • Validation using MolProbity and other tools

  • Deposition to the Protein Data Bank

This comprehensive approach will allow researchers to obtain experimental structural data to complement the existing computational model .

How can site-directed mutagenesis be utilized to investigate the catalytic mechanism of E. ictaluri pepQ?

Site-directed mutagenesis offers powerful insights into the catalytic mechanism of E. ictaluri pepQ. Based on structural prediction and sequence homology, the following approach is recommended:

• Identification of target residues:

  • Catalytic triad/tetrad residues identified through structural analysis and sequence alignment

  • Metal-binding residues (Xaa-Pro dipeptidases typically require metal ions for activity)

  • Substrate-binding pocket residues

  • Residues potentially involved in conformational changes

• Mutagenesis strategy:

  • Conservative substitutions (e.g., Asp→Asn, Glu→Gln) to probe electrostatic contributions

  • Alanine scanning to eliminate side chain functions

  • Introduction of non-natural amino acids for specialized mechanistic studies

• Experimental protocol:

  • Design primers with 15-20 bp flanking sequences around the mutation site

  • Use Q5 or Pfu polymerase for high-fidelity PCR

  • Confirm mutations by sequencing

  • Express and purify mutant proteins using identical conditions as wild-type

• Functional characterization of mutants:

  • Determine enzymatic parameters (kcat, KM) for each mutant

  • Compare thermal stability using differential scanning fluorimetry

  • Assess structural changes through circular dichroism

  • Perform substrate specificity profiling

• Data analysis and interpretation:

  • Construct a detailed catalytic mechanism model

  • Map mutations onto the structural model

  • Determine structure-function relationships

This systematic mutagenesis approach can reveal the molecular basis of E. ictaluri pepQ catalysis and substrate specificity.

What methodologies can researchers use to study kinetic parameters of recombinant E. ictaluri pepQ?

For comprehensive kinetic characterization of recombinant E. ictaluri pepQ, the following methodologies are recommended:

• Steady-state kinetics analysis:

  • Determine KM and Vmax using varying substrate concentrations

  • Calculate kcat based on enzyme concentration

  • Plot data using Michaelis-Menten, Lineweaver-Burk, and Eadie-Hofstee transformations

  • Use non-linear regression for parameter estimation

• Substrate specificity profiling:

  • Test a panel of Xaa-Pro dipeptides (varying the N-terminal amino acid)

  • Determine specificity constants (kcat/KM) for each substrate

  • Create a specificity profile based on relative values

• pH-dependent activity profile:

  • Measure activity across pH range 5.0-9.0

  • Use appropriate buffer systems (MES, HEPES, Tris)

  • Determine pH optimum and inflection points

  • Analyze ionization states of catalytic residues

• Temperature effects:

  • Determine temperature optimum

  • Calculate activation energy using Arrhenius plot

  • Assess thermal stability through activity retention

• Metal ion dependency:

  • Test activity with/without metal chelators (EDTA, EGTA)

  • Reactivation studies with different metal ions (Zn2+, Mn2+, Co2+)

  • Determine metal binding affinities

Example data presentation:

This comprehensive kinetic analysis will provide insights into the catalytic efficiency and specificity of E. ictaluri pepQ.

How does E. ictaluri pepQ compare structurally and functionally with Xaa-Pro dipeptidases from other bacterial species?

Comparative analysis of E. ictaluri pepQ with other bacterial Xaa-Pro dipeptidases reveals important evolutionary and functional relationships:

• Structural comparison:

  • The computed structure model of E. ictaluri pepQ (AF_AFC5BCB6F1) shows the characteristic fold of Xaa-Pro dipeptidases

  • Key structural elements include the catalytic domain and metal-binding sites

  • Structural alignments with homologous enzymes can identify conserved and divergent regions

• Sequence conservation analysis:

  • Multiple sequence alignment with Xaa-Pro dipeptidases from related species

  • Identification of highly conserved residues that may be essential for function

  • Analysis of species-specific sequence variations that may relate to substrate preferences

• Functional comparison:

  • Substrate specificity profiles compared across species

  • Catalytic efficiency (kcat/KM) for model substrates

  • Inhibitor sensitivity patterns

• Phylogenetic analysis:

  • Construction of phylogenetic trees based on Xaa-Pro dipeptidase sequences

  • Correlation of enzymatic properties with evolutionary relationships

  • Identification of potential horizontal gene transfer events

• Comparative genomic context:

  • Analysis of gene neighborhoods across species

  • Identification of conserved operonic structures

  • Inference of functional contexts and metabolic roles

This comprehensive comparative analysis provides insights into the evolutionary trajectory of pepQ enzymes and helps identify species-specific adaptations that may relate to the ecological niche or pathogenic lifestyle of E. ictaluri.

What are the implications of E. ictaluri pepQ in bacterial pathogenesis research?

Understanding E. ictaluri pepQ's role in pathogenesis requires integrating molecular function with infection biology:

• Potential roles in virulence:

  • Proteolytic processing of host proteins

  • Nutrient acquisition during infection

  • Evasion of host immune responses

  • Contribution to bacterial metabolism under stress conditions

• Gene expression analysis:

  • Quantitative RT-PCR to measure pepQ expression during infection

  • RNA-seq to place pepQ in the context of the infection transcriptome

  • Identification of regulatory elements controlling pepQ expression

• Construction of pepQ knockout and complemented strains:

  • Use the balanced-lethal system methodology similar to that described for asdA

  • Design deletion constructs targeting the pepQ gene

  • Create complementation plasmids expressing wild-type pepQ

  • Confirm genotypes by PCR and phenotypes by enzyme activity assays

• Infection models:

  • Cell culture-based infection assays

  • Animal infection models

  • Comparison of wild-type, ΔpepQ, and complemented strains

  • Measurement of bacterial persistence, replication, and host responses

• Interaction with host signaling pathways:

  • Similar to studies on E. ictaluri EseN, which affects host MAP kinases

  • Investigation of pepQ effects on host cell signaling

  • Analysis of host transcriptional responses to wild-type vs. ΔpepQ infection

This research direction can provide valuable insights into the potential contributions of pepQ to E. ictaluri pathogenesis and might identify new targets for intervention strategies.

What optimization strategies improve recombinant E. ictaluri pepQ yield and solubility?

Optimizing the expression and solubility of recombinant E. ictaluri pepQ requires systematic adjustments to multiple parameters:

• Expression vector optimization:

  • Testing different promoter strengths (T7, tac, araBAD)

  • Incorporating solubility-enhancing fusion tags (MBP, SUMO, TRX)

  • Codon optimization for the expression host

  • Inclusion of appropriate signal sequences for periplasmic expression

• Expression conditions:

  • Induction at lower temperatures (16-25°C)

  • Reduced inducer concentrations

  • Extended expression periods (overnight)

  • Addition of osmolytes or chaperone co-expression

• Media formulation:

  • Rich media (e.g., TB, 2×YT) versus minimal media

  • Supplementation with trace elements

  • Carbon source optimization

  • Addition of specific amino acids or cofactors

• Cell lysis and protein extraction:

  • Buffer optimization (pH, ionic strength, additives)

  • Gentle lysis methods to preserve protein structure

  • Inclusion of protease inhibitors

  • Solubilization strategies for inclusion bodies if necessary

A systematic approach using design of experiments (DoE) methodology similar to that used for optimizing acid protease production can identify optimal conditions efficiently.

Example optimization table:

The optimal conditions determined through this process will maximize both yield and activity of the recombinant enzyme.

How can researchers troubleshoot expression and purification issues with recombinant E. ictaluri pepQ?

When encountering difficulties with expression or purification of recombinant E. ictaluri pepQ, a systematic troubleshooting approach is essential:

• Low expression levels:

  • Verify plasmid sequence integrity

  • Test multiple expression hosts (BL21, Rosetta, Arctic Express)

  • Optimize codon usage for the expression host

  • Evaluate promoter leakiness and toxicity effects

  • Implement auto-induction media strategies

• Protein insolubility:

  • Test expression at lower temperatures (16-20°C)

  • Co-express with molecular chaperones (GroEL/ES, DnaK/J)

  • Add solubility enhancers to lysis buffer (glycerol, arginine, proline)

  • Consider alternative solubilization strategies

  • Evaluate different fusion tags (MBP, SUMO, TRX)

• Purification challenges:

  • Optimize binding and elution conditions for affinity chromatography

  • Implement on-column refolding protocols if necessary

  • Test alternative buffer compositions to improve stability

  • Add stabilizing agents (glycerol, reducing agents, specific metal ions)

  • Consider size exclusion chromatography under native conditions

• Loss of activity:

  • Test enzyme activity immediately after cell lysis

  • Monitor activity throughout purification steps

  • Evaluate buffer components for inhibitory effects

  • Add cofactors or metal ions that might be required for activity

  • Optimize storage conditions to maintain stability

• Protein degradation:

  • Add protease inhibitor cocktails during lysis and purification

  • Reduce purification time by optimizing protocols

  • Work at lower temperatures throughout

  • Verify if autodegradation is occurring

  • Consider adding stabilizing agents

This structured troubleshooting approach has proven effective for other difficult-to-express bacterial proteins and should resolve common issues with recombinant E. ictaluri pepQ production.

What advanced biophysical techniques provide insights into E. ictaluri pepQ structure-function relationships?

Advanced biophysical techniques offer deeper insights into E. ictaluri pepQ structure, dynamics, and function:

• Circular dichroism (CD) spectroscopy:

  • Secondary structure composition analysis

  • Thermal stability assessment

  • Conformational changes upon substrate or inhibitor binding

  • pH-dependent structural transitions

• Differential scanning calorimetry (DSC):

  • Precise determination of thermal transition midpoints

  • Evaluation of domain stability and cooperativity

  • Effects of ligands on protein stability

  • Comparison of wild-type and mutant stability profiles

• Isothermal titration calorimetry (ITC):

  • Direct measurement of binding thermodynamics

  • Determination of KD, ΔH, ΔS, and binding stoichiometry

  • Characterization of substrate and inhibitor interactions

  • Metal ion binding studies

• Small-angle X-ray scattering (SAXS):

  • Low-resolution solution structure determination

  • Analysis of oligomeric states

  • Conformational changes in solution

  • Complementary data to crystal structures

• Hydrogen-deuterium exchange mass spectrometry (HDX-MS):

  • Mapping regions of structural flexibility

  • Identification of binding interfaces

  • Conformational dynamics analysis

  • Effects of mutations on protein dynamics

• Nuclear magnetic resonance (NMR) spectroscopy:

  • Backbone assignments for smaller domains

  • Binding site mapping through chemical shift perturbations

  • Dynamics studies at different timescales

  • Metal binding site characterization

Integration of these complementary techniques provides a comprehensive understanding of E. ictaluri pepQ structure-function relationships beyond what is possible with any single method.

How can researchers develop specific inhibitors for E. ictaluri pepQ?

Development of specific inhibitors for E. ictaluri pepQ follows a rational design approach:

• Initial inhibitor screening:

  • Test known Xaa-Pro dipeptidase inhibitors (e.g., aminobenzylphosphonic acid derivatives)

  • Screen peptide-based libraries containing proline mimetics

  • Evaluate natural product collections

  • Perform high-throughput screening with diverse compound libraries

• Structure-based design:

  • Use computational models or crystal structures to identify binding pockets

  • Perform molecular docking studies with candidate inhibitors

  • Design transition-state analogs based on catalytic mechanism

  • Identify species-specific features that can enhance selectivity

• Medicinal chemistry optimization:

  • Establish structure-activity relationships (SAR)

  • Optimize potency through systematic modifications

  • Improve selectivity against homologous human enzymes

  • Enhance physicochemical properties for cellular studies

• Inhibitor characterization:

  • Determine IC50 and Ki values

  • Establish inhibition mechanisms (competitive, non-competitive, uncompetitive)

  • Perform X-ray crystallography of enzyme-inhibitor complexes

  • Evaluate effects on bacterial growth and virulence

• Cellular and in vivo validation:

  • Test effects on bacterial cultures

  • Evaluate toxicity in host cell models

  • Assess efficacy in infection models

  • Determine pharmacokinetic properties

This systematic approach can lead to the development of specific inhibitors that may serve as chemical probes for understanding pepQ function or as leads for potential antimicrobial development.

How can systems biology approaches integrate E. ictaluri pepQ into bacterial metabolic networks?

Systems biology approaches can contextualize E. ictaluri pepQ within broader bacterial metabolic and regulatory networks:

• Metabolomics studies:

  • Compare metabolite profiles between wild-type and ΔpepQ mutants

  • Identify accumulated dipeptides in the absence of pepQ

  • Track metabolic flux using isotope-labeled substrates

  • Construct metabolic maps showing pepQ-dependent pathways

• Transcriptomics integration:

  • RNA-seq analysis under various growth conditions

  • Identification of co-regulated genes

  • Construction of gene regulatory networks

  • Comparison with homologous systems in related bacteria

• Protein-protein interaction studies:

  • Affinity purification coupled with mass spectrometry

  • Bacterial two-hybrid screening

  • In vitro reconstitution of multiprotein complexes

  • Validation of interactions through co-immunoprecipitation

• Computational modeling:

  • Integration of pepQ into genome-scale metabolic models

  • Flux balance analysis to predict metabolic outcomes

  • Simulation of growth phenotypes under various conditions

  • Prediction of synthetic lethal interactions

• Comparative systems analysis:

  • Cross-species comparison of pepQ-containing pathways

  • Evolutionary analysis of metabolic network architecture

  • Identification of conserved and species-specific regulatory features

This integrated approach will provide a comprehensive understanding of pepQ's role within the broader context of E. ictaluri metabolism and pathogenesis.

What cutting-edge techniques can advance our understanding of E. ictaluri pepQ in host-pathogen interactions?

Emerging technologies offer new opportunities to understand E. ictaluri pepQ's role in host-pathogen interactions:

• CRISPR interference (CRISPRi) approaches:

  • Tunable repression of pepQ expression

  • Creation of depletion strains for essential genes

  • Combinatorial gene knockdowns to identify synthetic interactions

  • Time-resolved analysis of pepQ function during infection

• Proximity labeling proteomics:

  • APEX2 or BioID fusion to pepQ

  • Identification of proximal proteins in living bacteria

  • Mapping of protein neighborhoods during infection

  • Temporal changes in protein associations

• Host-pathogen protein-protein interaction mapping:

  • Split reporter systems to detect interactions in situ

  • Mass spectrometry-based interactomics

  • Protein complementation assays

  • Fluorescence resonance energy transfer (FRET) imaging

• Single-cell analysis:

  • Transcriptional reporters to monitor pepQ expression

  • Single-cell RNA-seq of infected host cells

  • Spatial transcriptomics of infected tissues

  • Correlating bacterial pepQ activity with host cell responses

• In vivo imaging:

  • Activity-based probes for pepQ function

  • Intravital microscopy to track bacteria during infection

  • Correlating pepQ activity with infection dynamics

  • Real-time monitoring of host responses

Similar to studies on E. ictaluri T3SS effector EseN , these approaches can reveal how pepQ contributes to bacterial survival and host response modulation during infection.